In accordance with the requirements of the Center for Drug Evaluation (CDE) of the National Medical Products Administration, Shenzhen Sciencare Medical Industries Co., Ltd.  held a summary report on the Phase II clinical trial of naltrexone implant in Beijing by video conference.